SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-008009
Filing Date
2024-01-26
Accepted
2024-01-26 17:00:10
Documents
2
Period of Report
2023-01-16

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1598
2 EX-24 hlvx-ex24.htm EX-24 12837
  Complete submission text file 0000950170-24-008009.txt   15869
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Issuer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O HILLEVAX, INC. 321 HARRISON AVE, SUITE 500 BOSTON MA 021118
Business Address
McLoughlin Sean (Reporting) CIK: 0002007879 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41365 | Film No.: 24568732